Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: A new treatable disorder
Open Access
- 23 August 2012
- journal article
- case report
- Published by Wiley in Movement Disorders
- Vol. 27 (10), 1317-1322
- https://doi.org/10.1002/mds.25138
Abstract
Background: The first gene causing early‐onset generalized dystonia with brain manganese accumulation has recently been identified. Mutations in the SLC30A10 gene, encoding a manganese transporter, cause a syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia. Methods: We present 10‐year longitudinal clinical features, MRI data, and treatment response to chelation therapy of the originally described patient with a proven homozygous mutation in SLC30A10. Results: The patient presented with early‐onset generalized dystonia and mild hyperbilirubinemia accompanied by elevated whole‐blood manganese levels. T1‐sequences in MRI showed hyperintensities in the basal ganglia and cerebellum, characteristic of manganese deposition. Treatment with intravenous disodium calcium edetate led to clinical improvement and reduction of hyperintensities in brain imaging. Conclusions: We wish to highlight this rare disorder, which, together with Wilson's disease, is the only potentially treatable inherited metal storage disorder to date, that otherwise can be fatal as a result of complications of cirrhosis. © 2012 Movement Disorder SocietyKeywords
This publication has 50 references indexed in Scilit:
- Syndrome of Hepatic Cirrhosis, Dystonia, Polycythemia, and Hypermanganesemia Caused by Mutations in SLC30A10 , a Manganese Transporter in ManAmerican Journal of Human Genetics, 2012
- Mutations in SLC30A10 Cause Parkinsonism and Dystonia with Hypermanganesemia, Polycythemia, and Chronic Liver DiseaseAmerican Journal of Human Genetics, 2012
- Welding and ParkinsonismNeurologic Clinics, 2011
- Manganese Toxicity in a Child With Iron Deficiency and PolycythemiaJournal of Child Neurology, 2011
- Ferroportin is a manganese‐responsive protein that decreases manganese cytotoxicity and accumulationJournal of Neurochemistry, 2010
- Manganese in Parenteral Nutrition: Who, When, and Why Should We Supplement?Gastroenterology, 2009
- Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degenerationMovement Disorders, 2008
- Manganese targets m‐aconitase and activates iron regulatory protein 2 in AF5 GABAergic cellsJournal of Neuroscience Research, 2007
- Neuroprotective treatment with Cerebrolysin in patients with acute stroke: a randomised controlled trialJournal of Neural Transmission, 2004
- Dimercaptosuccinic acid (DMSA): negligible effect on manganese in urine and blood.Occupational and Environmental Medicine, 1995